| Health / Medical Topics |
Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201
A non-small cell lung cancer (NSCLC) vaccine containing modified mRNAs encoding cancer-testis antigen NY-ESO-1, melanoma-associated antigens C1 (MAGE-C1/CT7) and C2 (MAGE-C2/CT10), survivin, and the oncofetal antigen 5T4 with potential antitumor and immunomodulatory activities. Upon subcutaneous administration, non-small cell lung cancer mRNA-derived vaccine CV9201 may stimulate the immune system to mount a cytotoxic, antigen-specific T lymphocyte response (CTL) against NSCLC cells. The modified mRNAs in this vaccine are taken up by cells after injection and exhibit enhanced translational potency. The five tumor-associated antigens (TAAs) encoded by these mRNAs are frequently expressed by NSCLC cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look…
A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell…
Any adverse experience that does not meet the definition of serious. Non-serious adverse events are classified as mild, moderate and severe. …
A group of testicular cancers that begin in the germ cells (cells that give rise to sperm). Nonseminomas are identified by the…
A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins. As a result, none…
Research animal models that do not include mice, rats, etc, but that might include non-human primates, cats, dogs, and others.
